Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$116.7M
+54.5% from 2023
Prescriptions
5,896
$19,798.89 per claim
Patients
868
935 prescribers
Total spending, 2024
$116.7M
$134,486.48 per patient
Medicare prescription drug plans paid $116.7M for Lorbrena in 2024, for 5,896 prescriptions and refills to 868 patients (up 54.5% from 2023). The average cost per claim was $19,798.89.
California had the highest Medicare cost for Lorbrena in 2024: $19.8M for 977 claims, followed by New York ($10.5M).
Alexander I Spira, medical oncology in Fairfax, VA, had the highest Medicare cost for Lorbrena in 2024: 58 claims costing $1.2M.
Lorbrena is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Alexander I Spira Fairfax, VA | Medical Oncology | 58 | Under 11 | $1.2M |
| Jamie E Chaft New York, NY | Medical Oncology | 37 | Under 11 | $710K |
| Collin Blakely |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 582 | 3,323 | 530 | $61.9M |
| 2023 | 683 | 3,788 | 604 | $75.6M |
| 2024 | 935 | 5,896 | 868 | $116.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Medical Oncology |
| 30 |
| Under 11 |
| $660K |
| Alexander D Fuld White River Junction, VT | Medical Oncology | 29 | Under 11 | $594K |
| Benjamin Creelan Tampa, FL | Medical Oncology | 26 | Under 11 | $557K |
| Jeanne G Vaughn Boston, MA | Nurse Practitioner | 28 | Under 11 | $547K |
| Liza C Villaruz Pittsburgh, PA | Medical Oncology | 23 | Under 11 | $501K |
| Eleanor G Hardy Charleston, SC | Physician Assistant | 25 | Under 11 | $497K |
| Michael R Shafique Tampa, FL | Medical Oncology | 23 | Under 11 | $488K |
| J Paul Marcoux II Boston, MA | Medical Oncology | 26 | Under 11 | $481K |
| Tina Cascone Houston, TX | Internal Medicine | 26 | Under 11 | $478K |
| Charles Lu Tampa, FL | Medical Oncology | 21 | Under 11 | $473K |
| Misako Nagasaka Orange, CA | Hematology-Oncology | 23 | Under 11 | $470K |
| Shira Lichtman New York, NY | Nurse Practitioner | 24 | Under 11 | $465K |
| Khrister-Nikka A Berkowitz Los Angeles, CA | Nurse Practitioner | 24 | Under 11 | $459K |
| Jennifer E Jacky Seattle, WA | Nurse Practitioner | 17 | Under 11 | $456K |
| Petros G Nikolinakos Athens, GA | Medical Oncology | 21 | Under 11 | $454K |
| Orion M Howard Bennington, VT | Medical Oncology | 22 | Under 11 | $454K |
| Caitlin C Meservey Ann Arbor, MI | Physician Assistant | 23 | Under 11 | $449K |
| Evan W Alley Weston, FL | Hematology-Oncology | 21 | Under 11 | $446K |
| Kathryn A Gold La Jolla, CA | Medical Oncology | 23 | Under 11 | $446K |
| Ber-Yuh Yang Flushing, NY | Hematology-Oncology | 23 | Under 11 | $443K |
| Jeffrey J Levine Bethesda, MD | Hematology-Oncology | 18 | Under 11 | $418K |
| Sara E Stevens Boston, MA | Nurse Practitioner | 20 | Under 11 | $418K |
| Jonathan W Goldman Santa Monica, CA | Hematology-Oncology | 22 | Under 11 | $417K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Pfizer US Pharm PFE | 5,896 | $116.7M |